Drugs like Wegovy, Ozempic, Mounjaro and Zepbound are rapidly growing in popularity as weight-loss treatments. These ...

Highlights Semaglutide medications like Ozempic may cause facial changes. You can take steps to help minimize or prevent ...

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy.

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are ...

Novo Nordisk notified the Food and Drug Administration about several hundred units of fake semaglutide 1.0 mg in the US drug ...

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper supervision, and a protein-rich diet, the results of a new study suggest.

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

Semaglutide is an injectable medication that treats type 2 diabetes and obesity by regulating blood sugar levels. A ...

While it is understood that the drugs have also proven to be safe and effective for thousands, the negative issues have led ...

Weight-loss jabs and those for diabetes may be linked to a lower risk of dementia, a study suggests. Semaglutide in particular, whose brand names include Wegovy and Ozempic, showed promise in cutting ...